S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NYSE:HUM

Humana (HUM) Stock Forecast, Price & News

$439.62
+7.62 (+1.76%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$426.24
$440.85
50-Day Range
$420.04
$465.49
52-Week Range
$351.20
$472.68
Volume
646,808 shs
Average Volume
887,111 shs
Market Capitalization
$55.61 billion
P/E Ratio
18.65
Dividend Yield
0.73%
Beta
0.86
30 days | 90 days | 365 days | Advanced Chart
Receive HUM News and Ratings via Email

Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter.

Humana logo

About Humana

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Hospital & medical service plans
Sub-Industry
Managed Health Care
Sector
Medical
CUSIP
44485910
Employees
95,500
Year Founded
1961

Sales & Book Value

Annual Sales
$83.06 billion
Cash Flow
$26.79 per share
Book Value
$121.29 per share

Profitability

Net Income
$2.93 billion
Pretax Margin
4.09%

Debt

Price-To-Earnings

Miscellaneous

Free Float
126,000,000
Market Cap
$55.61 billion
Optionable
Optionable

Company Calendar

Ex-Dividend for 4/29 Dividend
3/30/2022
Last Earnings
4/27/2022
Dividend Payable
4/29/2022
Today
5/22/2022
Next Earnings (Estimated)
7/27/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

2.77 out of 5 stars

Medical Sector

40th out of 1,416 stocks

Hospital & Medical Service Plans Industry

4th out of 13 stocks

Analyst Opinion: 2.4Community Rank: 4.4Dividend Strength: 3.3Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -













Humana (NYSE:HUM) Frequently Asked Questions

Is Humana a buy right now?

17 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Humana in the last twelve months. There are currently 5 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Humana stock.
View analyst ratings for Humana
or view top-rated stocks.

Are investors shorting Humana?

Humana saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 1,190,000 shares, a drop of 15.6% from the April 15th total of 1,410,000 shares. Based on an average daily volume of 969,200 shares, the days-to-cover ratio is presently 1.2 days. Currently, 1.0% of the company's stock are sold short.
View Humana's Short Interest
.

When is Humana's next earnings date?

Humana is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022.
View our earnings forecast for Humana
.

How were Humana's earnings last quarter?

Humana Inc. (NYSE:HUM) announced its quarterly earnings results on Wednesday, April, 27th. The insurance provider reported $8.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.83 by $1.21. The insurance provider earned $23.97 billion during the quarter, compared to the consensus estimate of $23.54 billion. Humana had a net margin of 3.51% and a trailing twelve-month return on equity of 17.27%. The firm's revenue for the quarter was up 16.0% compared to the same quarter last year. During the same period last year, the firm earned $7.67 EPS.
View Humana's earnings history
.

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana declared a quarterly dividend on Thursday, April 21st. Stockholders of record on Thursday, June 30th will be given a dividend of $0.7875 per share on Friday, July 29th. This represents a $3.15 annualized dividend and a yield of 0.72%. The ex-dividend date is Wednesday, June 29th.
View Humana's dividend history
.

Is Humana a good dividend stock?

Humana pays an annual dividend of $3.15 per share and currently has a dividend yield of 0.73%. Humana has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Humana is 13.36%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Humana will have a dividend payout ratio of 11.39% next year. This indicates that Humana will be able to sustain or increase its dividend.
View Humana's dividend history.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY 2022 earnings guidance on Tuesday, March, 29th. The company provided EPS guidance of $24.000-$ for the period, compared to the consensus EPS estimate of $24.130. The company issued revenue guidance of -.

What price target have analysts set for HUM?

17 Wall Street analysts have issued 1-year target prices for Humana's shares. Their forecasts range from $415.00 to $530.00. On average, they anticipate Humana's stock price to reach $490.28 in the next year. This suggests a possible upside of 11.5% from the stock's current price.
View analysts' price targets for Humana
or view top-rated stocks among Wall Street analysts.

Who are Humana's key executives?
Humana's management team includes the following people:
  • Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 60, Pay $3.92M) (LinkedIn Profile)
  • Ms. Susan Marie Diamond, Chief Financial Officer (Age 48, Pay $1.39M)
  • Mr. Timothy S. Huval, Chief Admin. Officer (Age 56, Pay $1.43M) (LinkedIn Profile)
  • Mr. T. Alan Wheatley, Segment Pres of Retail (Age 54, Pay $1.41M)
  • Dr. William Kevin Fleming Pharm.D., PharmD, RPh, Chief Corp. Affairs Officer & Segment Pres of Pharmacy Solutions (Age 54, Pay $1.22M)
  • Mr. Michael A. Koeberlein, Sr. VP, Chief Accounting Officer & Controller (Age 53)
  • Mr. Sam M. Deshpande, Chief Information Officer (Age 57) (LinkedIn Profile)
  • Lisa M. Stoner, VP of Investor Relations
  • Mr. Joseph C. Ventura, Chief Legal Officer (Age 45)
  • Amy Fry, Sr. VP of Corp. Communications
What is Bruce D. Broussard's approval rating as Humana's CEO?

1,597 employees have rated Humana CEO Bruce D. Broussard on Glassdoor.com. Bruce D. Broussard has an approval rating of 87% among Humana's employees.

Who are some of Humana's key competitors?
What other stocks do shareholders of Humana own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA), Boeing (BA), Salesforce (CRM), Johnson & Johnson (JNJ) and JPMorgan Chase & Co. (JPM).

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

Who are Humana's major shareholders?

Humana's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.29%), Vanguard Group Inc. (8.64%), Wellington Management Group LLP (6.94%), State Street Corp (4.47%), Capital Research Global Investors (3.29%) and Capital International Investors (2.65%). Company insiders that own Humana stock include Bruce D Broussard, Christopher H Hunter, David A Jr/Ky Jones, David A Jr/Ky Jones, Jorge S Mesquita, Samir Deshpande, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming.
View institutional ownership trends for Humana
.

Which institutional investors are selling Humana stock?

HUM stock was sold by a variety of institutional investors in the last quarter, including Harris Associates L P, American Century Companies Inc., Capital World Investors, Jennison Associates LLC, Ardevora Asset Management LLP, Bellevue Group AG, KBC Group NV, and Ceredex Value Advisors LLC. Company insiders that have sold Humana company stock in the last year include Bruce D Broussard, David A Jr/Ky Jones, Samir Deshpande, Timothy S Huval, and William Kevin Fleming.
View insider buying and selling activity for Humana
or view top insider-selling stocks.

Which institutional investors are buying Humana stock?

HUM stock was acquired by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Starboard Value LP, Vanguard Group Inc., First Trust Advisors LP, BlackRock Inc., Arrowstreet Capital Limited Partnership, Capital Research Global Investors, and Twin Tree Management LP.
View insider buying and selling activity for Humana
or or view top insider-buying stocks.

How do I buy shares of Humana?

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Humana's stock price today?

One share of HUM stock can currently be purchased for approximately $439.62.

How much money does Humana make?

Humana has a market capitalization of $55.61 billion and generates $83.06 billion in revenue each year. The insurance provider earns $2.93 billion in net income (profit) each year or $23.569990 on an earnings per share basis.

How many employees does Humana have?

Humana employs 95,500 workers across the globe.

Does Humana have any subsidiaries?

The following companies are subsidiares of Humana: 154th Street Medical Plaza, 516-526 West Main Street Condominium Council of Co-Owners, 54th Street Medical Plaza, American Eldercare, American Eldercare of North Florida, Anvita Health, Arcadian Health Plan, Arcadian Management Services, Atlantis Physician Group, CAC Medical Center Holdings, CAC-Florida Medical Centers, CDO 1, CDO 2, CHA HMO, CHA Service Company, Care Partners Home Care, CareNetwork, CarePlus Health, CarePlus Health Plans, Cariten Health Plan Inc., Certify Data Systems, CompBenefits, CompBenefits Company, CompBenefits Corporation, CompBenefits Dental, CompBenefits Direct, CompBenefits Insurance Company, Complex Clinical Management, Concentra Managed Care, Continucare Corporation, Continucare MDHC, Continucare MSO, Continucare Medical Management, Dental Care Plus Management, DentiCare, Emphesys, Emphesys Insurance Company, Enclara Healthcare, FPG, FPG Acquisition Corp., FPG Acquisition Holdings Corp., FPG Senior Services, Family Physicians of Winter Park, Go365, HUM Provider Holdings, HUM-e-FL, Harris Rothenberg International, Health Value Management, Humana Active Outlook, Humana At Home (Dallas), Humana At Home (Houston), Humana At Home (San Antonio), Humana At Home (TLC), Humana At Home 1, Humana Behavioral Health, Humana Benefit Plan of Illinois, Humana Dental Company, Humana Digital Health and Analytics Platform Services, Humana EAP and Work-Life Services of California, Humana Employers Health Plan of Georgia, Humana Government Business, Humana Health Benefit Plan of Louisiana, Humana Health Company of New York, Humana Health Insurance Company of Florida, Humana Health Plan, Humana Health Plan of California, Humana Health Plan of Ohio, Humana Health Plan of Texas, Humana Health Plans of Puerto Rico, Humana Healthcare Research, Humana Inc., Humana Innovation Enterprises, Humana Insurance Company, Humana Insurance Company of Kentucky, Humana Insurance Company of New York, Humana Insurance of Puerto Rico, Humana Management Services of Puerto Rico, Humana MarketPOINT, Humana MarketPOINT of Puerto Rico, Humana Medical Plan, Humana Medical Plan of Michigan, Humana Medical Plan of Pennsylvania, Humana Medical Plan of Utah, Humana Pharmacy, Humana Pharmacy Solutions, Humana Regional Health Plan, Humana Veterans Healthcare Services, Humana WellWorks LLC, Humana Wisconsin Health Organization Insurance Corporation, Humana at Home, HumanaDental, HumanaDental Insurance Company, Humco, Hummingbird Coaching Systems LLC, Independent Care Health Plan, KMG America, Kindred Healthcare, MCCI Group Holdings, MCCI Holdings, MCCI Medical Group, MCCI Specialty, MCCI/Lifetime of Aventura, MD Care, METCARE of Florida, Managed Care Indemnity, Medical Care Consortium Incorporated of Texas, MetCare, Metropolitan Health Networks, Naples Health Care Specialists, North Region Providers, Nursing Solutions, OSF HealthCare, PHP Companies, Partners in Integrated Care, Preferred Health Partnership, Preservation on Main, Primary Care Holdings, Primary Care Holdings II, Primary Care Specialists of the Palm Beaches, RMA Medical Centers of Florida, RMA Medical Group of Florida, ROHC, SeniorBridge, SeniorBridge Family Companies (CT), SeniorBridge Family Companies (FL), SeniorBridge Family Companies (IN), SeniorBridge Family Companies (MO), SeniorBridge Family Companies (NY), SeniorBridge-Florida, Texas Dental Plans, The Dental Concern, Transcend Population Health Management, and Transcend Population Health Management II.

When was Humana founded?

Humana was founded in 1961.

What is Humana's official website?

The official website for Humana is www.humana.com.

How can I contact Humana?

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at (502) 580-1000, via email at [email protected], or via fax at 502-580-3639.

This page was last updated on 5/22/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.